Population pharmacokinetics of piperacillin based on multicenter data to support model-informed precision dosing in critically ill women
Antimicrobial Agents and Chemotherapy · 04.11.2026 · 70 (11)
DOI: 10.1128/aac.00986-26 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Antimicrobial Agents and Chemotherapy, erschienen am 04.11.2026. Verfasst von Sebastian Greppmair und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anaesthesiology, LMU University Hospital, LMU Munich, Munich, Germany. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Piperacillin. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: German Research Council (DFG).
Abstract (Originalsprache)
Sex-specific differences in pharmacokinetics are increasingly recognized as clinically relevant, yet most population pharmacokinetic models for antibiotics have been developed in predominantly male populations with limited transferability to female patients. This study aimed to develop and externally evaluate a population pharmacokinetic model of piperacillin specifically for critically ill women to support model-informed precision dosing (MIPD). A total of 923 samples from 165 critically ill women (from four previously published studies) receiving piperacillin/tazobactam were analyzed. The data set was randomly split into a training set (80%) and an independent external evaluation set (20%). Non-linear mixed-effects modeling was employed based on the training data using NONMEM, and covariates were identified using stepwise covariate modeling with cross-validation. Prediction accuracy and bias were quantified using the median prediction error (MDPE) and the median absolute prediction error (MDAPE) in an MIPD scenario. Model predictions for future concentrations were generated both a priori and through Bayesian forecasting based on one prior sample. A two-compartment model provided the best fit for the data. Clearance was significantly affected by renal function estimated by the Cockcroft–Gault equation, along with procalcitonin and serum albumin. The external evaluation demonstrated strong predictive performance with very low systematic bias. In the MIPD scenario, a priori predictions exhibited good predictive performance (MDPE < |5.2|%, MDAPE < 33.4%), which substantially improved with Bayesian forecasting (MDPE < |3.2|%, MDAPE < 19.1%). A female-specific population pharmacokinetic model of piperacillin was developed and externally validated, demonstrating robust predictive performance and clear benefits for Bayesian forecasting.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anaesthesiology, LMU University Hospital, LMU Munich, Munich, Germany.
- Department of Anaesthesiology and Intensive Care Medicine, General Hospital of Heidenheim, Heidenheim, Germany.
- Department of Pharmacy, General Hospital of Heidenheim, Heidenheim, Germany.
- Laboratory Dr. Brunner, Laboratory Medical Care Center Konstanz GmbH, Constance, Germany.
- Institute for Infectious Diseases and Infection Control, Jena University Hospital, Friedrich-Schiller-University Jena, Jena, Germany.
- Department of Clinical Pharmacy, Institute of Pharmacy, University of Hamburg, Hamburg, Germany.
ORCID-Profile: Sebastian Greppmair, Sina Pesthy, Michael Zoller, Christina Scharf, Johannes Zander, Stefan Hagel, Sebastian G Wicha, Christoph Dorn, Uwe Liebchen
Förderung
- German Research Council (DFG)
Zitieren
APA
Greppmair, S., Pesthy, S., Zoller, M., Scharf, C., Brinkmann, A., Frey, O., Zander, J., Liebchen, N., Hagel, S., Wicha, S. G., Dorn, C., Böing, S., & Liebchen, U. (2026). Population pharmacokinetics of piperacillin based on multicenter data to support model-informed precision dosing in critically ill women. Antimicrobial Agents and Chemotherapy, 70(11). https://doi.org/10.1128/aac.00986-26
Vancouver
Greppmair S, Pesthy S, Zoller M, Scharf C, Brinkmann A, Frey O, et al. Population pharmacokinetics of piperacillin based on multicenter data to support model-informed precision dosing in critically ill women. Antimicrobial Agents and Chemotherapy. 2026;70(11). doi:10.1128/aac.00986-26
BibTeX
@article{Greppmair2026,
author = {Greppmair, Sebastian and Pesthy, Sina and Zoller, Michael and Scharf, Christina and Brinkmann, Alexander and Frey, Otto and Zander, Johannes and Liebchen, Nadine and Hagel, Stefan and Wicha, Sebastian G and Dorn, Christoph and Böing, Sabrina and Liebchen, Uwe},
title = {Population pharmacokinetics of piperacillin based on multicenter data to support model-informed precision dosing in critically ill women},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2026},
volume = {70},
number = {11},
doi = {10.1128/aac.00986-26}
}
EUVIMED